Gournay V, Vallet N, Peux V, Vera K, et al. Immune landscape after allo-HSCT: TIGIT and CD161-expressing CD4 T cells are associated with subsequent leukemia relapse. Blood 2022 Jul 12. pii: 485877. doi: 10.1182/blood.2022015522.
PMID: 35820057